This inventor holds 1 USPTO granted patent and 12 published patent applications and 2 EPO patents. Top assignees: Humabs Biomed Sa, Vir Biotechnology, Inc.. Active years: 2025.
Company Filing History:
1 out of 38 
1 out of 8 Years Active: 2025
Title: The Innovative Contributions of Phillip S. Pang
Introduction
Phillip S. Pang is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis B virus (HBV) infections. His innovative approach combines various therapies to enhance treatment efficacy.
Latest Patents
Phillip S. Pang holds a patent for a method titled "Combination HBV therapy." This patent outlines methods for treating HBV infection using combination therapies, which include an inhibitor of HBV gene expression or an agent that reduces HBV antigenic load, along with an anti-HBV antibody. This innovative therapy aims to improve patient outcomes in the management of HBV infections.
Career Highlights
Throughout his career, Phillip has worked with prominent companies in the biotechnology sector. He has been associated with Vir Biotechnology, Inc. and Humabs Biomed SA, where he has contributed to advancing research and development in viral therapies.
Collaborations
Phillip has collaborated with esteemed colleagues, including Anna Bakardjiev and Davide Corti. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.
Conclusion
Phillip S. Pang's contributions to HBV therapy exemplify the impact of innovative thinking in medicine. His work continues to influence the development of effective treatments for viral infections.